Medicaid’s Transportation Benefit and the People Who Use It
Medicaid’s non-emergency medical transportation (NEMT) benefit helps low-income enrollees get to care and accounts for…
Medicaid’s non-emergency medical transportation (NEMT) benefit helps low-income enrollees get to care and accounts for less than 1% of Medicaid spending. Amid the current administration’s focus on Medicaid fraud, this brief examines how states administer NEMT, what Medicaid spends on the program, and who uses it.
Brenda Connelly, president of The Springs Living, and Dave Wessinger, CEO of PointClickCare, discuss their co-development process
Why should Medicare determine who is qualified to provide remote monitoring by asking who employs the nurse, rather than who is accountable for the patient’s care? The post CMS Is Regulating the Wrong Thing — Here’s How to Fix Remote Patient Monitoring Without Losing the Care appeared first on MedCity News.
[Sponsored] BTK inhibitor has become an important treatment option for certain B-cell malignancies. The post How Innovation in BTK Inhibitor Development Is Improving Treatment Outcomes appeared first on MedCity News.
Companies aren’t slowing down to ask if AI is ready for mental health; they’re racing to build it in. Encoding the same unexamined standards into these tools means repeating the systemic issues marginalized groups have lived with for far too long. The post Mental Health Care Was Never Built for Everyone — AI Won’t Fix…
Eleven winning solutions recognized for innovation, measurable impact and real-world value across healthcare
When U.S. Rep. David Valadao defended voting for a bill aimed at reducing Medicare spending by billions, the Republican noted his role in securing a key provision that will require some adult beneficiaries to work — a mandate he called “not an unreasonable ask.” But the voters in his California Central Valley district, home to…
After years of searching for affordable health insurance, Trey Wright discovered Georgia Pathways to Coverage. The state’s limited Medicaid expansion program allowed the 27-year-old living in the rural city of Jesup in southeastern Georgia to finally visit a primary care doctor regularly. It also covered weekly shots to manage an array of allergies, saving him…
Midstream’s Series A round was led by Valtruis, and included participation from Andreessen Horowitz (a16z), Foundry and CommonSpirit Ventures. The post Midstream Health Snags $20M to Provide Health Systems More Financial Stability appeared first on MedCity News.
Setara Biosciences’ lead program is a potential treatment for the rare neuromuscular disorder Charcot-Marie-Tooth disease type 2C and the prevalent condition overactive bladder. This small molecule came from Actio Biosciences, which was recently acquired by Jazz Pharmaceuticals. The post Rare Disease Biotech Setara Starts Out With $90M and a Lead Drug in the Clinic appeared…